Contact

Dr Catherine Heath

Consultant Oncologist
MB, ChB(Hons), MRCP, FRCR

Practising at

Spire Southampton Hospital

Back to top

Treatment information

Some of the principal treatments carried out by Dr Catherine Heath at Spire include:

Other treatments

Prostate Cancer

Back to top

Professional profile

Dr Catherine Heath graduated from medical school in Sheffield in 1992 with Honours. She trained in general medicine in Sheffield passing the Membership of the Royal College of Physicians in 1995 and then went on to specialist training in Clinical Oncology at Leeds, becoming a Fellow of the Royal College of Radiologists in 1998. She spent a year in clinical research as a Clinical Fellow in the Palliative Radiation Oncology Program at Princess Margaret Hospital, Toronto, Canada between 2000/2001. Dr Heath was appointed Consultant Clinical Oncologist at Southampton in early 2002 with a subspecialty interest in urological malignancies. She is Lead Clinician for Urological Malignancies. Her main interests involve the non-surgical treatment of prostate cancer including radical external beam radiotherapy, permanent prostate brachytherapy seed implants, hormone therapy, chemotherapy and radio-isotope treatments for bone secondaries.

She also has interests in bladder cancer, radiotherapy for testicular cancer, and is the Lead Oncologist in Wessex for non-surgical treatment of penile cancer as part of the supra-regional multidisciplinary team led by Mr N Watkin at St George’s Hospital. Dr Heath set up and continues to run the Southampton Prostate Brachytherapy Seed Implant service in early 2006. Dr Heath is a founding member and executive committee member of the British Uro-Oncology Group. (Currently Treasurer).


Private contact details

Telephone 023 8076 4354
Private secretary Bev Stone
Private secretary telephone 023 8076 4354
Private secretary fax 023 8076 4369
Private secretary email bev.stone@spirehealthcare.com
Back to top

Current NHS posts

Consultant Clinical Oncologist Southampton University Hospitals NHS Trust.

Back to top

Personal Profile

  

Back to top

Financial Interests

Holds less than 0.1% of the shares in Spire Healthcare Group Plc

Back to top